Literature DB >> 18463625

Contributions of PK/PD modeling to intravenous anesthesia.

C F Minto1, T W Schnider.   

Abstract

Pharmacokinetic (PK)/pharmacodynamic (PD) modeling has made an enormous contribution to intravenous anesthesia. PK/PD models have provided us with insight into the factors affecting the onset and offset of drug effect. For example, we are now able to describe the influence of cardiac output on the disposition of intravenous drugs within the first few minutes after administration of the drug. We are able to calculate intravenous loading doses that allow for the delay between the concentration of the drug in the plasma and the rising concentration at the site of drug effect. We are able to achieve and maintain a stable level of anesthetic effect using computerized infusion pumps that target the site of drug effect rather than the plasma. Importantly, on the basis of models of drug interaction and an understanding of how drug offset varies with duration of administration, we are now able to rationally combine hypnotics and opioids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18463625     DOI: 10.1038/clpt.2008.100

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  12 in total

1.  A two-compartment effect site model describes the bispectral index after different rates of propofol infusion.

Authors:  Marcus A Björnsson; Ake Norberg; Sigridur Kalman; Mats O Karlsson; Ulrika S H Simonsson
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-04-23       Impact factor: 2.745

2.  Allometric or lean body mass scaling of propofol pharmacokinetics: towards simplifying parameter sets for target-controlled infusions.

Authors:  Johan Francois Coetzee
Journal:  Clin Pharmacokinet       Date:  2012-03-01       Impact factor: 6.447

3.  Pharmacokinetics and pharmacodynamics of a new reformulated microemulsion and the long-chain triglyceride emulsion of propofol in beagle dogs.

Authors:  S-H Lee; J-L Ghim; M-H Song; H-G Choi; B-M Choi; H-M Lee; E-K Lee; Y-J Roh; G-J Noh
Journal:  Br J Pharmacol       Date:  2009-12       Impact factor: 8.739

4.  Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction period.

Authors:  Jiayi Liu; Chunying Lu; Qirong Zou; Sheng Wang; Xuemei Peng
Journal:  Br J Clin Pharmacol       Date:  2016-10-16       Impact factor: 4.335

5.  Age progression from vicenarians (20-29 year) to nonagenarians (90-99 year) among a population pharmacokinetic/pharmacodynamic (PopPk-PD) covariate analysis of propofol-bispectral index (BIS) electroencephalography.

Authors:  Ashraf A Dahaba; Zhaoyang Xiao; Xiaoling Zhu; Hailong Dong; Lize Xiong; Peter Rehak; Sieglinde Zelzer; Kun Wang; Gilbert Reibnegger
Journal:  J Pharmacokinet Pharmacodyn       Date:  2020-02-25       Impact factor: 2.745

6.  Increasing interest in PK and PD studies has many advantages for anesthesiologists.

Authors:  Young-Cheol Woo
Journal:  Korean J Anesthesiol       Date:  2011-03-30

Review 7.  Beyond Genetics-Stratified and Personalised Medicines Using Multiple Parameters.

Authors:  Richard Peck; Patrick Smith
Journal:  Pharmaceuticals (Basel)       Date:  2010-05-25

8.  The optimal effect-site concentration of sufentanil for laryngeal mask insertion during induction with target-controlled propofol infusion at 4.0 μg/mL.

Authors:  Roshdi R Al-Metwalli
Journal:  Saudi J Anaesth       Date:  2014-04

9.  A Pharmacokinetics-Neural Mass Model (PK-NMM) for the Simulation of EEG Activity during Propofol Anesthesia.

Authors:  Zhenhu Liang; Xuejing Duan; Cui Su; Logan Voss; Jamie Sleigh; Xiaoli Li
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

10.  Explaining anaesthetic hysteresis with effect-site equilibration.

Authors:  Alex Proekt; Max B Kelz
Journal:  Br J Anaesth       Date:  2020-10-17       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.